Tumor diameter, size, lymph node metastasis, and distant metastasis are regarded as key indicators to determine tumor stage and prognosis of patients.[24] Subsequently, this study further evaluated the potential relationship between CASC11 and various clinical characteristics of patients with malignant tumors. Here, CASC11 is linked to metastatic malignant neoplasm in the lymph nodes.